Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

PolyPid Share Holder Equity 2019-2025 | PYPD

PolyPid share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  
PolyPid Annual Share Holder Equity
(Millions of US $)
2024 $8
2023 $-2
2022 $6
2021 $36
2020 $73
2019 $19
2018 $-82
PolyPid Quarterly Share Holder Equity
(Millions of US $)
2025-06-30 $20
2025-03-31 $0
2024-12-31 $8
2024-09-30 $2
2024-06-30 $2
2024-03-31 $7
2023-12-31 $-2
2023-09-30 $4
2023-06-30 $8
2023-03-31 $11
2022-12-31 $6
2022-09-30 $12
2022-06-30 $19
2022-03-31 $29
2021-12-31 $36
2021-09-30 $48
2021-06-30 $57
2021-03-31 $66
2020-12-31 $73
2020-09-30 $79
2020-06-30 $84
2020-03-31 $-93
2019-12-31 $19
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $-82
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.056B $0.000B
PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $71.679B 27.57
Zoetis (ZTS) United States $69.473B 25.20
Daiichi Sankyo, - (DSNKY) Japan $49.821B 25.53
Takeda Pharmaceutical (TAK) Japan $49.256B 10.05
BeOne Medicines - (ONC) Switzerland $33.903B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.730B 0.00
Summit Therapeutics (SMMT) United States $19.217B 0.00
Merck (MKKGY) Germany $16.847B 10.95
Shionogi (SGIOY) Japan $15.243B 15.27
United Therapeutics (UTHR) United States $13.824B 11.96
Neurocrine Biosciences (NBIX) United States $13.214B 39.42
Orion OYJ (ORINY) Finland $11.248B 27.11
IPSEN (IPSEY) France $11.218B 0.00
Eisai (ESAIY) $9.333B 10.53
Madrigal Pharmaceuticals (MDGL) United States $8.696B 0.00
Corcept Therapeutics (CORT) United States $7.418B 62.30
Grifols, S.A (GRFS) Spain $6.979B 0.00
Stevanato Group S.p.A (STVN) Italy $6.935B 40.89
Ionis Pharmaceuticals (IONS) United States $6.824B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.355B 18.39
Soleno Therapeutics (SLNO) United States $3.664B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.955B 14.05
Crinetics Pharmaceuticals (CRNX) United States $2.740B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.739B 0.00
Hypermarcas (HYPMY) Brazil $2.689B 20.21
Catalyst Pharmaceuticals (CPRX) United States $2.489B 8.34
Centessa Pharmaceuticals (CNTA) United Kingdom $2.314B 0.00
Ocular Therapeutix (OCUL) United States $2.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.703B 0.00
Guardian Pharmacy Services (GRDN) United States $1.649B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.581B 23.55
Ardelyx (ARDX) United States $1.443B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Harrow (HROW) United States $1.415B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.384B 0.00
Evotec AG (EVO) Germany $1.268B 0.00
Xeris Biopharma Holdings (XERS) United States $1.222B 0.00
Collegium Pharmaceutical (COLL) United States $1.209B 6.60
Enliven Therapeutics (ELVN) United States $1.165B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Akebia Therapeutics (AKBA) United States $0.827B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.742B 7.65
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
Theravance Biopharma (TBPH) United States $0.674B 55.79
ProKidney (PROK) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.645B 0.00
Siga Technologies (SIGA) United States $0.629B 7.77
Elite Pharmaceuticals (ELTP) United States $0.603B 0.00
Bioventus (BVS) United States $0.596B 14.42
Relay Therapeutics (RLAY) United States $0.586B 0.00
Organogenesis (ORGO) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.577B 0.00
USANA Health Sciences (USNA) United States $0.569B 11.65
Oruka Therapeutics (ORKA) United States $0.539B 0.00
Xencor (XNCR) United States $0.536B 0.00
Savara (SVRA) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.521B 0.00
Nektar Therapeutics (NKTR) United States $0.513B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Nanobiotix S.A (NBTX) France $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Aldeyra Therapeutics (ALDX) United States $0.337B 0.00
Altimmune (ALT) United States $0.320B 0.00
4D Molecular Therapeutics (FDMT) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.316B 0.00
Larimar Therapeutics (LRMR) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.95
AleAnna (ANNA) United States $0.274B 0.00
Galectin Therapeutics (GALT) United States $0.250B 0.00
OmniAb (OABI) United States $0.225B 0.00
Lyell Immunopharma (LYEL) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.199B 0.00
Aclaris Therapeutics (ACRS) United States $0.196B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.185B 0.00
Korro Bio (KRRO) United States $0.181B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.178B 27.50
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.125B 0.00
Avita Medical (RCEL) United States $0.125B 0.00
Avalo Therapeutics (AVTX) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.101B 22.88
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.097B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Liminatus Pharma (LIMN) United States $0.087B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.083B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Inotiv (NOTV) United States $0.057B 0.00
Karyopharm Therapeutics (KPTI) United States $0.056B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.55
Century Therapeutics (IPSC) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
FibroGen (FGEN) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.01
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.57
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.55
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00